Skip to content

Comparison of Anesthetic Outcomes between Supraglottic High-Frequency Jet Ventilation and Mask Ventilation during Modified Electroconvulsive Therapy: A Single-Center Randomized Controlled Trial

Comparison of Anesthetic Outcomes between Supraglottic High-Frequency Jet Ventilation and Mask Ventilation during Modified Electroconvulsive Therapy: A Single-Center Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120268
Enrollment
Unknown
Registered
2026-03-11
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The lowest value of SpO2 during modified electroconvulsion therapy (MECT)

Interventions

Supraglottic High-Frequency Jet Ventilation Group (H Group):Supraglottic High-Frequency Jet Ventilation (HFJV): Nasal insertion of Weil's nasopharyngeal jet tube, driving pressure 0.3 bar, initial fre
Mask Positive Pressure Ventilation Group (M Group):Mask Ventilation: Use of disposable anesthesia mask, oxygen concentration 100%, oxygen flow rate 6 L/min.

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have signed the informed consent form for MECT after being evaluated by a psychiatrist. 2. American Society of Anesthesiologists physical status I-III, aged 18-65 years. 3. No pulmonary infection or symptoms before operation (no abnormal chest X-ray or chest CT report; normal body temperature ;blood routine WBC(4-10)×10^9/L). 4. Agree to participate in this clinical trial and sign the informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: 1. Allergic to propofol, succinylcholine, soy or egg; 2. Difficult airway predicted before surgery (Mallampati grade III/IV, thyromental distance <6 cm, mouth opening <2 fingers); 3. Diseases affecting normal ventilation (nasal stenosis, rhinitis, etc.); 4.patients with severe heart, lung, brain and other vital organ lesions, or severe liver and renal dysfunction (Child-Pugh grade C, serum creatinine (Scr)=178µmol/L;Blood urea nitrogen (BUN) =9mmol/L); 5. Family members or patients refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
Minimum intraoperative SpO2;

Secondary

MeasureTime frame
Vital signs (heart rate, blood pressure, SpO2) at T1 (arrival), T2 (1 min after seizure termination), T3 (respiratory recovery), and T4 (awakening);Surgical duration;Recovery duration;Number of suctioning episodes;Incidence of postoperative pneumonia;Incidence of subclinical respiratory depression;Incidence of hypoxemia;Electroconvulsive therapy parameters (stimulus dose, convulsion duration, inhibition index);Gastric antral cross-sectional area under ultrasound before and after oxygen administration;Anesthesiologist satisfaction score;Psychiatrist satisfaction score;Nursing satisfaction score;

Countries

China

Contacts

Public ContactLuo Gangjian

The Third Affiliated Hospital of Sun Yat-sen University

luogj@mail.sysu.edu.cn+86 18922102871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026